Literature DB >> 18803735

Risk profiles for non-adherence to antipsychotic medications.

T V McCann1, G Boardman, E Clark, S Lu.   

Abstract

Poor adherence to medications is common in individuals with schizophrenia, and can lead to relapse and re-hospitalization. This paper presents the findings of an Australian study of the factors affecting antipsychotic medication taking in individuals with schizophrenia. The Factors Influencing Neuroleptic Medication Taking Scale was used with a non-probability sample of mental health service users. Ethics approval was obtained from a university and a hospital ethics committee. Data were analysed using spss version 15. Most participants had insight into their illness and were aware of the stigma of mental illness. Around 70% experienced annoying side effects, while nearly half admitted alcohol consumption. About one-fifth admitted they had missed taking medications during the previous week. Significant others played a variable role in medication taking. Over 80% were satisfied with their relationships with health professionals, but were less satisfied with access to these professionals, especially psychiatrists. Logistic regression analysis showed that age, impact of medication side effects, and access to psychiatrists were independent predictors of medication omission. It is argued that medication taking is a complex issue, which needs to be taken into consideration in health professional training and measures to promote adherence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803735     DOI: 10.1111/j.1365-2850.2008.01277.x

Source DB:  PubMed          Journal:  J Psychiatr Ment Health Nurs        ISSN: 1351-0126            Impact factor:   2.952


  15 in total

1.  Predictors of relapse in Chinese schizophrenia patients: a prospective, multi-center study.

Authors:  Yu-Tao Xiang; Chuan-Yue Wang; Yong-Zhen Weng; Qi-Jing Bo; Helen F K Chiu; Sandra S M Chan; Edwin H M Lee; Gabor S Ungvari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-03       Impact factor: 4.328

2.  Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.

Authors:  Pál Czobor; Richard A Van Dorn; Leslie Citrome; Rene S Kahn; W Wolfgang Fleischhacker; Jan Volavka
Journal:  Eur Neuropsychopharmacol       Date:  2015-04-30       Impact factor: 4.600

3.  Facilitators and barriers to the active participation of clients with serious mental illnesses in medication decision making: the perceptions of young adult clients.

Authors:  Jonathan Delman; Jack A Clark; Susan V Eisen; Victoria A Parker
Journal:  J Behav Health Serv Res       Date:  2015-04       Impact factor: 1.505

4.  Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions.

Authors:  Gabriel Gerlinger; Marta Hauser; Marc De Hert; Kathleen Lacluyse; Martien Wampers; Christoph U Correll
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

5.  Stigma of Mental Illness-1: Clinical reflections.

Authors:  Amresh Shrivastava; Megan Johnston; Yves Bureau
Journal:  Mens Sana Monogr       Date:  2012-01

Review 6.  Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.

Authors:  Peter M Haddad; Cecilia Brain; Jan Scott
Journal:  Patient Relat Outcome Meas       Date:  2014-06-23

Review 7.  Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness.

Authors:  Dawn I Velligan; Martha Sajatovic; Ainslie Hatch; Pavel Kramata; John P Docherty
Journal:  Patient Prefer Adherence       Date:  2017-03-03       Impact factor: 2.711

8.  Translation and cultural adaptation of Glasgow Antipsychotic Side-effects Scale (GASS) in Arabic.

Authors:  Yazed AlRuthia; Hadeel Alkofide; Fahad Dakheel Alosaimi; Hisham Alkadi; Albandari Alnasser; Aliah Aldahash; Arwa Basalamah; Maryam Alarfaj
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

Review 9.  Review of depot aripiprazole for schizophrenia.

Authors:  Farha Bilal Motiwala; Kim Stasia Siscoe; Rif S El-Mallakh
Journal:  Patient Prefer Adherence       Date:  2013-11-13       Impact factor: 2.711

10.  Study on psychoeducation enhancing results of adherence in patients with schizophrenia (SPERA-S): study protocol for a randomized controlled trial.

Authors:  Donatella Rita Petretto; Antonio Preti; Carlo Zuddas; Franco Veltro; Marco Bruno Luigi Rocchi; Davide Sisti; Valentina Martinelli; Mauro Giovanni Carta; Carmelo Masala
Journal:  Trials       Date:  2013-10-07       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.